Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 20
Filter
2.
Future Microbiol ; 18: 187-195, 2023 02.
Article in English | MEDLINE | ID: mdl-36820638

ABSTRACT

Aim: To assess the performance characteristics of a lab-developed multiplex PCR assay for the detection of common bacterial pathogens associated with infections in pediatric patients from normally sterile sites, such as cerebrospinal fluid, synovial and pleural fluids. Materials & methods: A total of 272 specimens were tested by PCR and traditional culture methods to assess the presence of Neisseria meningitidis, Streptococcus pneumoniae, Streptococcus pyogenes, methicillin-sensitive and methicillin-resistant Staphylococcus aureus and Kingella kingae. Results: Compared with culture, the overall positive and negative percentage agreement of the PCR were 95.9% and 74.1%, respectively. Conclusion: This sterile body fluid PCR affords a rapid and sensitive alternative for bacterial detection, allowing for more timely pathogen-directed antimicrobial therapy.


Subject(s)
Body Fluids , Methicillin-Resistant Staphylococcus aureus , Child , Humans , Multiplex Polymerase Chain Reaction , Streptococcus pyogenes/genetics , Streptococcus pneumoniae
3.
Mayo Clin Proc Innov Qual Outcomes ; 7(2): 93-98, 2023 Apr.
Article in English | MEDLINE | ID: mdl-36644594

ABSTRACT

Coronavirus disease 2019 (COVID-19) pandemic has led to considerable morbidity and mortality across the world. Lung transplant is a viable option for a few with COVID-19-related lung disease. Whom and when to transplant has been the major question impacting the transplant community given the novelty of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). We describe a pitfall of presumed prolonged shedding of SARS-CoV-2 in a patient with COVID-19 associated acute respiratory distress syndrome leading to COVID-19 pneumonia after lung transplant. This raises concerns that replication-competent SARS-CoV-2 virus can persist for months post-infection and can lead to re-infection of grafts in the future.

4.
J Vasc Surg Venous Lymphat Disord ; 11(1): 19-24.e3, 2023 01.
Article in English | MEDLINE | ID: mdl-36100130

ABSTRACT

OBJECTIVE: The purpose of the present study was to explore the racial disparities in the incidence of deep vein thrombosis (DVT), pulmonary embolism (PE), and acute kidney injury (AKI) in hospitalized patients with coronavirus disease 2019 (COVID-19). METHODS: A retrospective analysis was performed of prospectively collected data of consecutive COVID-19 patients hospitalized from March 11, 2020 to May 27, 2021. The primary outcome measures were the incidence of DVT/PE and mortality. The secondary outcome measures included differences in the length of hospitalization, need for intensive care unit care, readmission, and AKI. Multivariable regression models were used to assess for independent predictors of the primary and secondary outcome measures. RESULTS: The present study included 876 hospitalized patients with COVID-19. The mean age was 64.4 ± 16.2 years, and 355 were women (40.5%). Of the 876 patients, 694 (79.2%) had identified as White, 111 (12.7%) as Black/African American, 48 (5.5%) as Asian, and 23 (2.6%) as other. The overall incidence of DVT/PE was 8.7%. The DVT/PE incidence rates differed across the race groups and was highest for Black/African American patients (n = 18; 16.2%), followed by Asian patients (n = 5; 10.4%), White patients (n = 52; 7.5%), and other (n = 1; 4.4%; P = .03). All but one of the hospitalization outcomes examined demonstrated no differences according to race, including the hospitalization stay (P = .33), need for intensive care unit care (P = .20), readmission rates (P = .52), and hospital all-cause mortality (P = .29). The AKI incidence differed among races, affecting a higher proportion of Black/African American patients (P=.003). On multivariable regression analysis, Black/African American race (odds ratio [OR], 2.0; 95% confidence interval [CI], 1.0-4.0; P = .04) and higher D-dimer levels (OR, 1.1; 95% CI, 1.1-1.2; P < .0001) were predictors of DVT/PE. In addition, Black/African American race (OR, 2.3; 95% CI, 1.4-3.7; P = .001), lower hemoglobin levels (OR, 0.84; 95% CI, 0.8-0.9; P ≤ .0001), male sex (OR, 1.7; 95% CI, 1.2-2.4; P = .005), hypertension (OR, 2.1; 95% CI, 1.4-3.1; P = .0005), and older age (OR, 1.02; 95% CI, 1.006-1.03; P = .003) were predictors of AKI. CONCLUSIONS: In our single-center case series, we found a higher incidence of DVT/PE and AKI among Black/African American patients with COVID-19. Black/African American race and D-dimer levels were independent predictors of DVT/PE, and Black/African American race, hemoglobin, and D-dimer levels were independent predictors of AKI.


Subject(s)
Acute Kidney Injury , COVID-19 , Pulmonary Embolism , Venous Thrombosis , Humans , Male , Female , Middle Aged , Aged , Aged, 80 and over , COVID-19/diagnosis , Retrospective Studies , Risk Factors , Pulmonary Embolism/epidemiology , Acute Kidney Injury/diagnosis , Acute Kidney Injury/epidemiology , Acute Kidney Injury/therapy , Venous Thrombosis/epidemiology
5.
iScience ; 25(11): 105272, 2022 Nov 18.
Article in English | MEDLINE | ID: mdl-36213006

ABSTRACT

Blood neurofilament light chain (NFL) is proposed to serve as an estimate of disease severity in hospitalized patients with coronavirus disease 2019 (COVID-19). We show that NFL concentrations in plasma collected from 880 patients with COVID-19 within 5 days of hospital admission were elevated compared to controls. Higher plasma NFL associated with worse clinical outcomes including the need for mechanical ventilation, intensive care, prolonged hospitalization, and greater functional disability at discharge. No difference in the studied clinical outcomes between black/African American and white patients was found. Finally, vaccination associated with less disability at time of hospital discharge. In aggregate, our findings support the utility of measuring NFL shortly after hospital admission to estimate disease severity and show that race does not influence clinical outcomes caused by COVID-19 assuming equivalent access to care, and that vaccination may lessen the degree of COVID-19-caused disability.

6.
Lab Med ; 53(6): 580-584, 2022 Nov 03.
Article in English | MEDLINE | ID: mdl-35672905

ABSTRACT

OBJECTIVE: Using a US Food and Drug Administration (FDA) emergency use authorization (EUA) reverse transcription polymerase chain reaction (RT-PCR) method, we examined the analytic performance accuracy of saliva specimens as compared to nasopharyngeal (NP) specimens in symptomatic patients. Correlation between test results and symptoms was also evaluated. METHODS: Over a 5-week period in 2020, 89 matched saliva and nasopharyngeal swabs were collected from individuals exhibiting symptoms consistent with SARS-CoV-2. Specimens were tested with an FDA EUA-approved RT-PCR method, and performance characteristics were compared. RESULTS: The concordance rate between saliva and nasopharyngeal testing was 93.26%. The mean cycle threshold value of saliva when compared to the NP specimen was 3.56 cycles higher. As compared to NP swab, saliva testing demonstrates acceptable agreement but lower sensitivity. CONCLUSION: When compared to a reference method using NP swabs, the use of saliva testing proved to be a reliable method. Self-collected saliva testing for SARS-CoV-2 allows for a viable option when trained staff or collection materials are in short supply.


Subject(s)
COVID-19 , SARS-CoV-2 , Humans , SARS-CoV-2/genetics , Saliva , COVID-19/diagnosis , Nasopharynx , Specimen Handling
7.
J Vasc Surg Venous Lymphat Disord ; 10(3): 578-584.e2, 2022 05.
Article in English | MEDLINE | ID: mdl-35085829

ABSTRACT

OBJECTIVE: To investigate the radiographic resolution of acute pulmonary embolism (PE) using contrast-enhanced computed tomography (CECT) examinations in patients diagnosed with acute PE while hospitalized with coronavirus disease 2019 (COVID-19) and to understand the mid-term and long-term implications of anticoagulation therapy. METHODS: We identified patients with acute PE per CECT and at least one follow-up CECT from March 11, 2020, to May 27, 2021, using a prospective registry of all hospitalized patients with COVID-19 infection receiving care within a multicenter Health System. Initial and follow-up CECT examinations were reviewed independently by two radiologists to evaluate for PE resolution. The Modified Miller Score was used to assess for thrombus burden at diagnosis and on follow-up. RESULTS: Of the 6070 hospitalized patients with COVID-19 infection, 5.7% (348/6070) were diagnosed with acute PE and 13.5% (47/348) had a follow-up CECT examination. The mean ± standard deviation time to follow-up imaging was 44 ± 48 days (range, 3-161 days). Of 47 patients, 47 (72.3%) had radiographic resolution of PE, with a mean time to follow-up of 48 ± 43 days (range, 6-239 days). All patients received anticoagulation monotherapy for a mean of 149 ± 95 days and this included apixaban (63.8%), warfarin (12.8%), and rivaroxaban (8.5%), among others. The mean Modified Miller Score at PE diagnosis and follow-up was 4.8 ± 4.2 (range, 1-14) and 1.4 ± 3.3 (range, 0-16; P < .0001), respectively. Nine patients (19%) died at a mean of 13 ± 8 days after follow-up CECT (range, 1-27 days) and at a mean of 28 ± 16 days after admission (range, 11-68 days). Seen of the nine deaths (78%) deaths were associated with progression of COVID-19 pneumonia. CONCLUSIONS: Hospitalized patients with COVID-19 have a clinically apparent 5.7% rate of developing PE. In patients with follow-up imaging, 72.3% had radiographic thrombus resolution at a mean of 44 days while on anticoagulation. Prospective studies of the natural history of PEs with COVID-19 that include systematic follow-up imaging are warranted to help guide anticoagulation recommendations.


Subject(s)
Anticoagulants , COVID-19 Drug Treatment , COVID-19 , Pulmonary Embolism , Acute Disease , Anticoagulants/therapeutic use , COVID-19/complications , Humans , Prospective Studies , Pulmonary Embolism/diagnostic imaging , Pulmonary Embolism/drug therapy , Treatment Outcome
8.
Mayo Clin Proc Innov Qual Outcomes ; 6(2): 120-125, 2022 Apr.
Article in English | MEDLINE | ID: mdl-34926993

ABSTRACT

OBJECTIVE: To evaluate the magnitude of humoral response to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) messenger RNA (mRNA) vaccines in patients with cancer receiving active therapies. PATIENTS AND METHODS: Patients 18 years or older in whom SARS-CoV-2 spike antibody (anti-S Ab) levels were measured after 2 doses of SARS-CoV-2 mRNA vaccines were included. Patients with prior coronavirus disease 2019 (COVID-19) infection or receiving other immunosuppressive therapy were excluded. RESULTS: Among 201 patients who met the criteria, 61 were immunocompetent, 91 had a hematologic malignancy, and 49 had a solid malignancy while receiving treatments associated with cytopenia, including chemotherapy or cyclin-dependent kinase 4 and 6 inhibitors. A significantly greater proportion of immunocompetent patients (96.7% [59 of 61]) had anti-S Ab titers of 500 U/mL or greater compared to patients with hematologic (7.7% [7 of 91) and solid (55.1% [27 of 49]) malignancy (P<.001). Despite 2 doses of SARS-CoV-2 mRNA vaccines, 52.7% of patients with hematologic malignancy (48 of 91) and 8.2% of those with solid malignancy (4 of 49) receiving cytopenic therapy had no seroconversion (spike antibody titers <0.8 U/mL). Two patients subsequently had development of breakthrough COVID-19 infection after full vaccination. CONCLUSION: A substantial proportion of patients with hematologic and solid malignancies receiving chemotherapies and CDK4/6i had poor humoral responses after SARS-CoV-2 mRNA vaccination. Our study adds to a growing body of literature suggesting that immunosuppressed patients have a suboptimal humoral response to COVID-19 vaccination. Our study also underscores the importance of assessing antibody response after COVID-19 vaccines in these vulnerable patients.

9.
Ann Clin Lab Sci ; 51(6): 741-749, 2021 Nov.
Article in English | MEDLINE | ID: mdl-34921026

ABSTRACT

OBJECTIVE: The ongoing COVID-19 pandemic caused by SARS-CoV-2 has challenged diagnostic laboratories to re-examine traditional methods for collecting specimens and sample types used in molecular testing. Our goal was to demonstrate that saliva can be used for detecting SARS-CoV-2 and correlates well with established molecular methods using nasopharyngeal (NP) swabs. METHODS: We examined use of a saliva collection device in conjunction with a laboratory-developed real-time reverse transcription-polymerase chain reaction (LDPCR) method for detecting SARS-CoV-2 in a symptomatic population and compared results with 2 US Food and Drug Administration (FDA)-approved methods (emergency use authorization [EUA]) that use specimens from NP swabs. RESULTS: The sensitivity of LDPCR compared with the reference methods was 75.0% (21/28); specificity, 98.1% (104/106). When cycle threshold values were compared between paired specimens using the LDPCR and a EUA reverse transcription PCR method, both targeting the open-reading frame gene, the mean value for saliva was 4.66 cycles higher than for NP specimens. CONCLUSION: Use of self-collected saliva in conjunction with an LDPCR for SARS-CoV-2 compared favorably with 2 FDA EUA methods using NP swabs. The use of an alternative sample type and assay method will aid in expanding the availability of testing during the ongoing COVID-19 pandemic.


Subject(s)
COVID-19/diagnosis , SARS-CoV-2/genetics , Specimen Handling/methods , Adult , Aged , Aged, 80 and over , COVID-19/genetics , COVID-19 Nucleic Acid Testing/methods , Data Accuracy , Diagnostic Tests, Routine/methods , Female , Humans , Laboratories , Male , Middle Aged , Molecular Diagnostic Techniques/methods , Nucleic Acids/isolation & purification , Real-Time Polymerase Chain Reaction/methods , Reverse Transcriptase Polymerase Chain Reaction/methods , SARS-CoV-2/pathogenicity , Saliva/chemistry
10.
Sci Transl Med ; 13(602)2021 07 14.
Article in English | MEDLINE | ID: mdl-34131052

ABSTRACT

Brain imaging studies of patients with COVID-19 show evidence of macro- and microhemorrhagic lesions, multifocal white matter hyperintensities, and lesions consistent with posterior reversible leukoencephalopathy. Imaging studies, however, are subject to selection bias, and prospective studies are challenging to scale. Here, we evaluated whether serum neurofilament light chain (NFL), a neuroaxonal injury marker, could predict the extent of neuronal damage in a cohort of 142 hospitalized patients with COVID-19. NFL was elevated in the serum of patients with COVID-19 compared to healthy controls, including those without overt neurological manifestations. Higher NFL serum concentrations were associated with worse clinical outcomes. In 100 hospitalized patients with COVID-19 treated with remdesivir, a trend toward lower NFL serum concentrations was observed. These data suggest that patients with COVID-19 may experience neuroaxonal injury and may be at risk for long-term neurological sequelae. Neuroaxonal injury should be considered as an outcome in acute pharmacotherapeutic trials for COVID-19.


Subject(s)
COVID-19 , Tumor Necrosis Factor Ligand Superfamily Member 14 , Biomarkers , Humans , Intermediate Filaments , Magnetic Resonance Imaging , Neurofilament Proteins , Prospective Studies , SARS-CoV-2
11.
Cyberpsychol Behav Soc Netw ; 24(11): 722-728, 2021 Nov.
Article in English | MEDLINE | ID: mdl-33956536

ABSTRACT

Excessive social media has emerged as a potential behavioral addiction with multiple consequences, especially in young adulthood (18-24 years). This study aimed to assess the relationship between excessive social media use, sociodemographics, and psychosocial constructs in a Hispanic college student sample. College students (n = 621; n = 456 females; n = 160 males) from a university located on the U.S./Mexico border completed a survey assessing sociodemographics, social media addiction, social media use, and psychosocial constructs (e.g., Internet motives, sensation seeking, and need for drama [NFD]). Descriptive analyses were conducted, as were two linear regressions assessing weekly social media use and social media addiction. Participants reported using social media an average of 20 hours a week (SD = 19.47). In addition, 57.9 percent of participants reported using social media once a day or more, whereas 15.1 percent met the social media addiction threshold. Weekly social media use was positively associated with NFD, socialization, and coping as motives while being negatively associated with age. Social media addiction was positively associated with NFD and coping while being negatively associated with age. Findings suggest that Hispanic college students evidence high social media use rates and may be using social media as an unhealthy strategy to deal with negative mood and daily problems. Furthermore, college students may be using social media as an avenue to engage in attention-seeking behaviors and manipulation of others. Prospective studies are warranted to assess these relationships temporally, as are intervention efforts aimed at reducing excessive social media use.


Subject(s)
Social Media , Universities , Adult , Female , Hispanic or Latino , Humans , Male , Motivation , Students , Young Adult
12.
J Vasc Surg Venous Lymphat Disord ; 9(6): 1361-1370.e1, 2021 11.
Article in English | MEDLINE | ID: mdl-33836287

ABSTRACT

OBJECTIVE: We assessed the incidence of deep vein thrombosis (DVT) and pulmonary embolism (PE) in hospitalized patients with coronavirus disease 2019 (COVID-19) compared with that in a matched cohort with similar cardiovascular risk factors and the effects of DVT and PE on the hospital course. METHODS: We performed a retrospective review of prospectively collected data from COVID-19 patients who had been hospitalized from March 11, 2020 to September 4, 2020. The patients were randomly matched in a 1:1 ratio by age, sex, hospital of admission, smoking history, diabetes mellitus, and coronary artery disease with a cohort of patients without COVID-19. The primary end point was the incidence of DVT/PE and the odds of developing DVT/PE using a conditional logistic regression model. The secondary end point was the hospitalization outcomes for COVID-19 patients with and without DVT/PE, including mortality, intensive care unit (ICU) admission, ICU stay, and length of hospitalization (LOH). Multivariable regression analysis was performed to identify the variables associated with mortality, ICU admission, discharge disposition, ICU duration, and LOH. RESULTS: A total of 13,310 patients had tested positive for COVID-19, 915 of whom (6.9%) had been hospitalized across our multisite health care system. The mean age of the hospitalized patients was 60.8 ± 17.0 years, and 396 (43.3%) were women. Of the 915 patients, 82 (9.0%) had had a diagnosis of DVT/PE confirmed by ultrasound examination of the extremities and/or computed tomography angiography of the chest. The odds of presenting with DVT/PE in the setting of COVID-19 infection was greater than that without COVID-19 infection (0.6% [5 of 915] vs 9.0% [82 of 915]; odds ratio [OR], 18; 95% confidence interval [CI], 8.0-51.2; P < .001). The vascular risk factors were not different between the COVID-19 patients with and without DVT/PE. Mortality (P = .02), the need for ICU stay (P < .001), duration of ICU stay (P < .001), and LOH (P < .001) were greater in the DVT/PE cohort than in the cohort without DVT/PE. On multivariable logistic regression analysis, the hemoglobin (OR, 0.71; 95% CI, 0.46-0.95; P = .04) and D-dimer (OR, 1.0; 95% CI, 0.33-1.56; P = .03) levels were associated with higher mortality. Higher activated partial thromboplastin times (OR, 1.1; 95% CI, 1.00-1.12; P = .03) and higher interleukin-6 (IL-6) levels (OR, 1.0; 95% CI, 1.01-1.07; P = .05) were associated with a greater risk of ICU admission. IL-6 (OR, 1.0; 95% CI, 1.00-1.02; P = .05) was associated with a greater risk of rehabilitation placement after discharge. On multivariable gamma regression analysis, hemoglobin (coefficient, -3.0; 95% CI, 0.03-0.08; P = .005) was associated with a prolonged ICU stay, and the activated partial thromboplastin time (coefficient, 2.0; 95% CI, 0.003-0.006; P = .05), international normalized ratio (coefficient, -3.2; 95% CI, 0.06-0.19; P = .002) and IL-6 (coefficient, 2.4; 95% CI, 0.0011-0.0027; P = .02) were associated with a prolonged LOH. CONCLUSIONS: A significantly greater incidence of DVT/PE occurred in hospitalized COVID-19-positive patients compared with a non-COVID-19 cohort matched for cardiovascular risk factors. Patients affected by DVT/PE were more likely to experience greater mortality, to require ICU admission, and experience prolonged ICU stays and LOH compared with COVID-19-positive patients without DVT/PE. Advancements in DVT/PE prevention are needed for patients hospitalized for COVID-19 infection.


Subject(s)
COVID-19/complications , COVID-19/mortality , Critical Care , Hospitalization , Pulmonary Embolism/epidemiology , Venous Thrombosis/epidemiology , Aged , COVID-19/therapy , Case-Control Studies , Cohort Studies , Female , Humans , Incidence , Logistic Models , Male , Middle Aged , Pulmonary Embolism/virology , Risk Factors , Survival Rate , Venous Thrombosis/virology
13.
Thromb Update ; 5: 100090, 2021 Dec.
Article in English | MEDLINE | ID: mdl-38620680

ABSTRACT

Background: COVID-19-associated coagulopathy is incompletely understood. Objectives: To characterize thrombin generation, Von Willebrand Factor (VWF), neutrophil extracellular traps (NETs), and their role in COVID-19 risk stratification in the emergency department (ED). Patients/methods: Plasma samples from 67 ED COVID-19 patients were compared to 38 healthy volunteers (HVs). Thrombin generation (calibrated automated thrombogram, CAT) was expressed as lag time (LT, min), peak height (PH, min), and time to peak (ttPeak, min). Citrullinated nucleosomes and histones were quantified with ELISA, VWF antigen and activity (IU/dL) through latex immunoassay, Factor VIII (IU/dL) through one-stage optical clot detection, and VWF multimers with Western blot densitometry. Wilcoxon testing and multivariable logistic regression were performed. Results presented as median [Q1, Q3]; p < 0.05 significant. Results: COVID-19 patients had longer LT (4.00 [3.26, 4.67]; 2.95 [2.67, 3.10], p < 0.001) and ttPeak (7.33 [6.33, 8.04]; 6.45 [6.00, 7.50], p = 0.004), greater VWF antigen (212 [158, 275]; 110 [91, 128], p < 0.001) and Factor VIII levels (148 [106, 190]; 106 [86, 129], p < 0.001), with decreased high molecular weight multimers (Normalized multimer ratio 0.807 [0.759, 0.869]; 0.891 [0.858, 0.966], p < 0.001), than HVs. COVID-19 patients requiring admission from the ED had longer LT and ttPeak with greater VWF antigen and Factor VIII levels than those not admitted. Two and three variable models of CAT parameters and VWF correlated with COVID-19 and admission status (C-statistics 0.677 to 0.922). Conclusions: Thrombin generation kinetics and VWF levels, independent of NETs, may have a role in predicting admission need for COVID-19 patients.

14.
J Spine Surg ; 5(3): 351-357, 2019 Sep.
Article in English | MEDLINE | ID: mdl-31663046

ABSTRACT

BACKGROUND: The purpose of this study was to compare outcomes of patients with degenerative spondylolisthesis treated by posterolateral lumbar fusion (PLF) versus PLF with transforaminal lumbar interbody fusion (PLF + TLIF). Studies of PLF versus PLF + TLIF have shown either equivalence or support for PLF + TLIF in lumbar spine surgery. Many are heterogeneous in the conditions treated, with few considering only spondylolisthesis of degenerative origin. Radiographic outcomes tend to favor PLF + TLIF, but this has not translated into better clinical outcomes. METHODS: This was a retrospective cohort study. Forty-nine patients undergoing single-level PLF and seventy patients undergoing single-level PLF + TLIF with two-year follow-up were retrospectively reviewed. Demographics, Oswestry Disability Index (ODI), implant cost, surgical data, and complications were analyzed. RESULTS: There was no difference in ODI improvement at two-year follow-up between the cohorts (P=0.97). Dural tears were more common in the PLF cohort (P<0.01), but otherwise complication and reoperation rates were similar. Implant cost (P<0.01) and operative time (P=0.01) were higher in the PLF + TLIF cohort. CONCLUSIONS: The addition of a TLIF to a PLF did not result in a functional improvement in the treatment of degenerative spondylolisthesis as measured by the ODI.

15.
Case Rep Nephrol ; 2019: 7940291, 2019.
Article in English | MEDLINE | ID: mdl-31531252

ABSTRACT

We report a case of type I cryoglobulinemic glomerulonephritis in a patient with chronic hepatitis C who presented with acute renal failure. The renal biopsy revealed membranoproliferative GN (MPGN) due to cryoglobulinemia with unexpected monoclonal Kappa restriction on immunofluorescence microscopy, suggesting an underlying hematopoietic malignancy. The bone marrow biopsy revealed presence of marginal zone lymphoma. Our case raises awareness regarding possibility of monoclonality in the renal biopsy of HCV-infected patients and exemplifies the crucial role the renal biopsy plays in detecting lymphoid malignancies where clinical features are ambiguous.

16.
Case Rep Pathol ; 2018: 7462032, 2018.
Article in English | MEDLINE | ID: mdl-30050715

ABSTRACT

A solitary fibrous tumor (SFT) arising in the paratesticular region is a rare event. Typically most SFTs present as a lung mass and have a characteristic microscopic appearance. Although uncommon, SFTs may present at just about any anatomical site. Here we present a case of a SFT arising along the right spermatic cord, with histologic features mimicking a cellular angiofibroma. We describe the diagnostic immunohistochemical markers useful for arriving at its diagnosis. We also summarize our current understanding of the structural and molecular features that make up SFTs and discuss how these features may help us better understand the pathophysiology of pluripotent mesenchymal stem cell differentiation.

17.
Clin Spine Surg ; 31(8): 351-355, 2018 10.
Article in English | MEDLINE | ID: mdl-29889107

ABSTRACT

STUDY DESIGN: This study retrospectively reviewed recurrences of surgical site infections (SSI) in spinal patients treated with vacuum-assisted closure (VAC) technology. OBJECTIVE: Identify patient and treatment factors associated with recurrence of SSI after VAC treatment. SUMMARY OF BACKGROUND DATA: Patients treated with VAC can achieve healing of deep spine wound infections; however, some patients develop a recurrent infection. Risk factors associated with a recurrence have not been identified. MATERIALS AND METHODS: One hundred and eleven patients with SSI after spine surgery from 2002 to 2010 were studied. They had been treated with irrigation and debridement, placement of VAC, and IV antibiotics. They subsequently were taken to surgery for primary closure of their wound. Patients with SSI who healed after the initial infection treatment were compared with patients who experienced recurrence. Patient and treatment factors that were studied included smoking status, body mass index, obesity status, diagnosis of diabetes, fusion surgery, methicillin-resistant Staphylococcus aureus, or polybacteria infection, number of irrigation and debridement treatments before closure, duration of IV antibiotic treatment, and duration of treatment time with VAC. Patients with SSI who healed after the initial treatment were compared with patients who experienced recurrence. RESULTS: Fourteen patients had at least one recurrence of wound infection. None of the patient or treatment factors was associated with the recurrence of a SSI. CONCLUSIONS: Among spine surgery patients with a SSI treated with the VAC system, those factors which predispose a patient to develop a recurrent SSI remain unknown. LEVEL OF STUDY: Level IV.


Subject(s)
Negative-Pressure Wound Therapy/adverse effects , Spine/surgery , Surgical Wound Infection/etiology , Adult , Aged , Aged, 80 and over , Female , Humans , Male , Middle Aged , Recurrence , Surgical Wound Infection/microbiology , Time Factors
18.
Clin Chim Acta ; 484: 218-222, 2018 Sep.
Article in English | MEDLINE | ID: mdl-29807019

ABSTRACT

BACKGROUND: Concentrations gradients that form in plasma as a result of freezing and thawing is a well-known phenomenon. As the water fraction converts into ice, plasma constituents diffuse from the freezing front by natural convection in the liquid phase. This process can lead to erroneous lab results, if the sample is not thoroughly mixed prior to testing. METHODS: A series of patient samples received at the clinical chemistry core lab were found to have low sodium levels that normalized after tube inversion. We suspected that the samples may have frozen during shipping and therefore examined the effects of freezing and thawing on serum. RESULTS: Our investigation revealed that prior to arriving at the core lab, samples from one of our satellite clinics were undergoing a freeze-thaw cycle during shipping, which resulted in the formation of concentration gradients and spurious lab results on arrival. CONCLUSIONS: Large hospitals that have a central core lab and receive patient samples from satellite clinics need to be aware of this phenomena, which can contribute to erroneous lab results being posted in a patient's electronic medical record, resulting in a misdiagnosis.


Subject(s)
Diabetes Mellitus, Type 2/blood , Freezing , Sodium/blood , Humans , Male , Middle Aged
19.
J Clin Microbiol ; 56(3)2018 03.
Article in English | MEDLINE | ID: mdl-29305539

ABSTRACT

Rapid detection of group A Streptococcus (GAS) is an integral component of treatment decisions in the clinic, especially in the pediatric population. We prospectively collected 216 specimens from symptomatic, predominantly pediatric patients and evaluated the performance of the Alere i Strep A test (Alere i; Alere Inc., Scarborough, ME) and the BD Veritor system (BD Veritor; Becton, Dickinson and Company, Sparks, MD), with culture results being used as a comparator. Real-time PCR (RT-PCR) was performed as an arbiter in discordant cases. Comprehensive chart review was also done to determine the hypothetical impact of the results on antibiotic use. Alere i had a sensitivity and a specificity of 100% and 91.3%, respectively, and BD Veritor had a sensitivity and a specificity of 76.2% and 93.6%, respectively, when the results were compared to those of GAS culture. Further analysis of discordant results using RT-PCR revealed that while BD Veritor missed 13 confirmed positive cases, Alere i detected 100% (n = 13) of the same cases. Analysis of assay agreement showed that Alere i and BD Veritor had only moderate agreement (agreement = 0.888 [95% confidence interval {CI}, 0.838 to 0.927]; kappa index = 0.689 [95% CI, 0.91 to 0.974]). We also found both the underutilization and the overutilization of antibiotics based on the results of molecular testing. Overall, Alere i showed superior performance over BD Veritor in the detection of GAS pharyngitis and could potentially assist in better antibiotic utilization.


Subject(s)
Diagnostic Tests, Routine/standards , Streptococcal Infections/diagnosis , Streptococcus pyogenes/isolation & purification , Anti-Bacterial Agents/therapeutic use , Humans , Immunoassay/standards , Nucleic Acid Amplification Techniques/standards , Pharynx/microbiology , Prospective Studies , Reproducibility of Results , Sensitivity and Specificity , Streptococcal Infections/drug therapy
20.
J Stud Alcohol Drugs ; 74(2): 205-11, 2013 Mar.
Article in English | MEDLINE | ID: mdl-23384368

ABSTRACT

OBJECTIVE: Research in the area of bystander intervention in the prevention of alcohol-impaired driving (AID) has mostly focused on the influence of existing factors (such as status or relationships) on the likelihood of intervening and has relied mostly on samples of college-age students. It remains unknown whether exposure to external stimuli, such as that of mass media marketing, has the ability to influence bystander intervention and whether differential tendencies to intervene hold true for the larger population. This study sought to explore the influence of external stimuli, in the form of mass media AID prevention messaging, on tendencies of bystander intervention and to determine other factors predictive of bystander intervention. METHOD: The study relied on national, nonprobability survey data of mostly non-college-age respondents collected to assess anti-AID media campaigns. Analyses entailed a series of ordinary least squares and binary logistic regression models. RESULTS: Exposure to an AID media prevention campaign was not significantly related to individual concern over AID in the community or whether a bystander intervened to prevent an incident of AID. Seventy-six percent of respondents reported exposure to AID media prevention campaigns, whereas slightly more than 40% reported actually intervening to prevent an AID incident. Intervening bystanders had greater odds of being female and non-White and of perceiving the legal consequences of AID as being certain and severe. These factors, however, were mediated by respondent concern regarding the seriousness of the AID problem in their community. CONCLUSIONS: Findings suggest that AID media-based prevention messaging works best among those in the population who view AID as a serious problem in their community.


Subject(s)
Alcoholic Intoxication/prevention & control , Automobile Driving , Helping Behavior , Mass Media , Adult , Aged , Aged, 80 and over , Alcohol Drinking/prevention & control , Data Collection , Female , Humans , Least-Squares Analysis , Logistic Models , Male , Middle Aged , Young Adult
SELECTION OF CITATIONS
SEARCH DETAIL
...